Streetbeat News

Stock Prices

STAF

Staffing 360 Solutions (NASDAQ:STAF) reported Q4 sales of $69.58 million, missing the analyst consensus estimate of $76.24 million by 8.73%. However, this is a 37% increase over sales of $50.79 million in the same period last year.

Portfolio Pulse from Happy Mohamed

May 22, 2023 | 12:29 pm

IMMX

Immix Biopharma announced positive clinical results for NXC-201, showing a 100% overall response rate in DARZALEX-relapsed or refractory AL amyloidosis patients in the ongoing NEXICART-1 Phase 1b/2a trial.

Portfolio Pulse from Benzinga Newsdesk

May 22, 2023 | 12:29 pm

LUXH

LuxUrban Hotels (NASDAQ:LUXH) has increased its 2023 EBITDA forecast to $25M-$30M from $21M-$25M and initiated 2024 net rental revenue and EBITDA guidance of $220M-$240M and $48M-$60M, respectively. This follows an agreement with pre-IPO investors eliminating $87.5M in revenue share payments in exchange for 6,740,000 shares.

Portfolio Pulse from Benzinga Newsdesk

May 22, 2023 | 12:28 pm

LUXH

LuxUrban Hotels (NASDAQ:LUXH) has entered into an agreement with its pre-IPO investors to eliminate $87.5M in revenue share payments in exchange for a one-time issuance of 6.74M shares. The agreement is expected to improve the company's cash position, increase margins, and future cash flows. LuxUrban Hotels has also increased its 2023 EBITDA guidance and initiated 2024 net rental revenue and EBITDA guidance.

Portfolio Pulse from Benzinga Newsdesk

May 22, 2023 | 12:26 pm

FRLN

Freeline Therapeutics' shares are trading higher after the company received ILAP designation in the U.K. by MHRA for LFT201.

Portfolio Pulse from Benzinga Newsdesk

May 22, 2023 | 12:23 pm

ICPT

HC Wainwright & Co. analyst Ed Arce downgraded Intercept Pharma (NASDAQ:ICPT) from Neutral to Sell and lowered the price target from $14 to $8.

Portfolio Pulse from richadhand@benzinga.com

May 22, 2023 | 12:21 pm

MU

Micron Technology (MU) clarified that smartphones are not included in the percentage range for the impact expected from the ongoing chip shortage.

Portfolio Pulse from Benzinga Newsdesk

May 22, 2023 | 12:21 pm

VLCN

Volcon announced a proposed public equity offering, causing its shares to trade lower.

Portfolio Pulse from Benzinga Newsdesk

May 22, 2023 | 12:20 pm

HEPA

Hepion Pharmaceuticals announced positive results from its phase 2 study to treat liver function, leading to a surge in its share prices.

Portfolio Pulse from Benzinga Newsdesk

May 22, 2023 | 12:18 pm

ZIM

ZIM Integrated Shipping reported a year-over-year decrease in Q1 EPS results and worse-than-expected Q1 sales results, causing its shares to trade lower.

Portfolio Pulse from Benzinga Newsdesk

May 22, 2023 | 12:16 pm